Navigation Links
Neurocrine Biosciences Reports Third Quarter 2009 Results
Date:10/28/2009

cessed via the webcast through the Company's website at http://www.neurocrine.com

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the conference call will be available approximately one hour after the conclusion of the call by dialing 1-800-723-2156 (US) or 402-220-2660 (International) using the passcode 7NEURO. The call will be archived for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com

In addition to historical facts, this press release may contain forward-looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's GnRH program, R & D pipeline and Company overall. Specifically, the risks and uncertainties the Company faces with respect to the Company's GnRH program include risk that the elagolix clinical trials will fail to demonstrate that elagolix is safe and effective; risk that elagolix will not proceed to later stage clinical trials; and risks associated with the Company's dependence on corporate c
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
2. Neurocrine Biosciences Presents Elagolix Data
3. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
4. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
5. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
6. Neurocrine Biosciences Reports First Quarter 2008 Results
7. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
8. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
9. Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
10. Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea
11. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 2014  New data demonstrates that flibanserin, a novel, ... of female sexual dysfunction, Hypoactive Sexual Desire Disorder (HSDD), ... in premenopausal women when taken at bedtime. The data ... North America,s (SMSNA) 20th Annual Fall ... SMSNA accepted this study as a late ...
(Date:11/22/2014)... -- Statistics released from a number of organizations show ... the holidays, beginning with Thanksgiving eve, which is now ... The data, highlighted in an Infographic released ... their annual Sober Days for the Holidays public ... and increased rates of DUI injuries and deaths during ...
(Date:11/22/2014)... 2014 Many power shifts are occurring ... of patients in the biopharmaceutical market is impacting ... than ever, understanding how to effectively acquire, convert, ... essential. According to recent research ... spent about two-thirds of their patient-focused dollars on ...
Breaking Medicine Technology:Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3Alarming Stats Show Holiday Drinking an Issue for Many 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2
... Food and Drug,Administration (FDA) today proposed that makers ... warning on,their products' labeling to include warnings about ... suicidality, in young,adults ages 18 to 24 during ... , The proposed labeling changes also include language ...
... England, 26th April 2007 - CeNeS Pharmaceuticals plc,(LSE: ... the United States Food and Drug Administration (FDA),has ... the,clinical development of morphine-6-glucuronide (M6G), its novel,drug for ... announced results of a Phase III study of ...
Cached Medicine Technology:FDA Proposes New Warnings About Suicidal Thinking, Behavior in,Young Adults Who Take Antidepressant Medications 2FDA Proposes New Warnings About Suicidal Thinking, Behavior in,Young Adults Who Take Antidepressant Medications 3FDA approves IND on Lead Product M6G 2
(Date:11/24/2014)... November 24, 2014 From embedded sensors and ... of fitness technology will take center stage at the ... at the 2015 International CES® , January 6, ... Level 2, Bellini 2004). The bond between fitness and technology ... less about devices and more about the human body. , ...
(Date:11/24/2014)... 24, 2014 Abington Health ... has joined The Neurology Group and has been ... Center. , A graduate of Vinnica Medical University ... Albert Einstein Medical Center in Philadelphia and completed a ... Sclerosis Center at Weill Cornell Medical College. Ternopolska is ...
(Date:11/24/2014)... New York (PRWEB) November 24, 2014 ... contacted by the Family and Children's Association ... such as soap, shampoo, mouthwash and other such items.The ... citizens who are home bound, living in nursing homes, ... intended to greatly enhance the well being of seniors ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 ReAdmission ... and disease management services to health plans, hospitals, ... Essette’s Medical Management software suite. ReAdmission Solutions ... in a program to reduce patients' avoidable readmissions ... Health Management, Care Management, Utilization Management, and Appeals ...
(Date:11/23/2014)... well-known wedding dress manufacturer, has unveiled its new collection of ... offered at deeply discounted prices, up to 75 percent off. ... The main purpose of the promotion is to expand iFitDress.com’s ... ideal options for ladies who are eager to look charming ... mint cocktail dresses are very beautiful; they are made with ...
Breaking Medicine News(10 mins):Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 2Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 3Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 4Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2
... women expect to go through common symptoms during pregnancy, such as morning ... to deal with them when they come. At Gurgle, we offer a ... cope with these symptoms. , ... London, England (PRWEB) April 2, 2009 ...
... symptoms of the autistic condition Asperger Syndrome, such as a ... to levels of the stress hormone cortisol, suggests new research ... a surge of this hormone shortly after waking, with levels ... makes the brain alert, preparing the body for the day ...
... social care services face a host of new challenges ... personal budgets* in social care. The issues raised for ... are outlined in ,The impact of personal budgets on ... booklet highlights the views of leading experts on social ...
... and San DiegoST. JOSEPH, Mo., April 1 This spring, ... pets, hearts checked is a walk in the park. ... make stops in April 4 and 5 with a sound-proof ... perform free heart examinations of area dogs.In addition to performing ...
... Susan G. Komen Detroit Race for the ... Ann Karmanos Cancer Institute, join other Komen Affiliates ... applaud the introduction of the 21st Century Cancer ... Treatment) Act, bipartisan legislation co-sponsored by Sens. Edward ...
... ADDISON, Texas, April 1 ULURU ... announced today that clinical evidence on the treatment ... the physical properties of Altrazeal(TM) Silver will be presented at ... 2009. The work will be presented in podium presentations ...
Cached Medicine News:Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 2Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 3Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 4Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 5Health News:Autism linked with stress hormone levels 2Health News:Third sector gears up to meet 2Health News:Third sector gears up to meet 3Health News:Mobile Dog Heart Health Tour Through California Cities to Provide Free Heart Examinations in Sound-Proof Setting 2Health News:Mobile Dog Heart Health Tour Through California Cities to Provide Free Heart Examinations in Sound-Proof Setting 3Health News:Komen Detroit and the Karmanos Cancer Institute Applaud Introduction of Bipartisan Cancer Alert Act 2Health News:Komen Detroit and the Karmanos Cancer Institute Applaud Introduction of Bipartisan Cancer Alert Act 3Health News:Komen Detroit and the Karmanos Cancer Institute Applaud Introduction of Bipartisan Cancer Alert Act 4Health News:Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Conference 2009 2Health News:Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Conference 2009 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: